spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Turkish Cargo expands the ‘Pharma Corridor’ in its wide flight network.

Turkish Cargo


Turkish Cargo, the fastest growing global air cargo brand thanks to its wide flight network, keeps bringing health to the world by carrying pharmaceuticals between destinations certified by the global aviation authorities.

The successful brand has created a pharma corridor between over 400 stations by carrying pharmaceuticals in important and certified destinations such as Mumbai, Brussels, Istanbul, Singapore, Dubai, Basel, London, and Amsterdam.

Turkish Airlines Chief Cargo Officer, Turhan Özen said; “As Turkish Cargo, we carry out the pharmaceutical transports from Atatürk and Istanbul Airports that have been certified by the global air cargo authorities and thus hold the IATA CEIV certificate within the cold chain integrity. While maintaining our successful Dual Hub operations, we carry out the land transports between two airports by using active temperature-controlled vehicles that hold all the necessary international certificates to preserve the cold chain integrity. Besides, the natural hub Istanbul, which is at the center of gravity of the air cargo trade, provides the appropriate climate conditions for the time and temperature sensitive cargo transportation throughout the year. Together with our flag-carrier master brand Turkish Airlines, we aim to become one of the top three air bridges of the world.”

Operating in 15 stations that hold the IATA CEIV (Center of Excellence for Independent Validators) certificate, Turkish Cargo also has completed the IATA CEIV Pharma certificate renewal process for Atatürk Airport and is qualified for the the same certificate for Istanbul Airport (IST) now as well. The global air cargo brand, which serves in 14 stations that hold the EU's Good Distribution Practice certificate, also carries out its pharmaceutical transport operations in 40 stations that hold QEP (Qualified Envirotainer Provider) certificate and ensures active temperature control between destinations that are thousands of kilometers far from each other.

Maintaining its operations in compliance with the global air cargo standards in 126 countries of the world, Turkish Cargo continues to offer active and passive solutions for medicine consignments through its storage areas within the temperature range of -20/+25° C that meet high quality standards along with temperature-controlled wide body and cargo aircraft.

Covering the world with its wide flight network composed of over 300 stations with 88 of them being direct cargo destinations, Turkish Cargo continues to be a preferred brand in air cargo transportation sector by ensuring a sustainable growth with its infrastructure, operational capabilities, fleet, and specialist teams.

To view the flight schedules and details please visit www.turkishcargo.com.tr, or contact with the call center at +90 850 333 0 777.

To view the flight schedules and details please visit www.turkishcargo.com.tr, or contact with the call center at +90 850 333 0 777.
phone +90 212 463 63 63
web www.turkishcargo.com.tr/en
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Signant Health Unveils its full Conference Line-up for SCOPE 2020

PHILADELPHIA, PA – February 11, 2020: The SCOPE Summit for Clinical Operations Executives annually convenes innovative thought leaders from across the life sciences industry to share ideas, challenges and best practices that will help drive change and improve patient centricity throughout the coming year and beyond. Subject matter experts from Signant Health will host and participate in key discussions on the importance of eConsent and patient engagement, the impact of data analytics on endpoint quality, and how to integrate sensors and wearables into eCOA trials as part of the patient journey through clinical research.
More info >>


White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

Industry Events

Bio Integrates 2020

21 May 2020, Leonardo Royal Hotel London Tower Bridge UK

Bio Integrates 2020 is a one-day gathering of biotech, pharma, CDMO & CRO organisations as well as clinicians, patient groups and regulators to provide a platform to discuss the major challenges impacting the biotech sector. There will be in excess of 250 senior industry executives and 70 + speakers participating.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement